Amphastar Pharmaceuticals (AMPH) PT Lowered to $30 at Wells Fargo
Tweet
Share
E-mailGet Alerts AMPH Hot Sheet
Price: $21.60 -0.37%
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Wells Fargo analyst Benjamin Burnett lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $30.00 (from $34.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Amphastar Pharmaceuticals (AMPH) PT Raised to $23 at Barclays
- Palmer Square Capital BDC (PSBD) PT Lowered to $10.25 at BofA Securities
- Deere (DE) PT Lowered to $728 at UBS as Agricultural Machinery Cycle Gets Closer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
